In conclusion, by means of a bioinformatics analysis, the highlighted findings of our research identified DDX24 as an adverse indicator of HCC prognosis and that it was significantly related to the pathways modulating tumor development. This evidence concerns the gene DDX24 and hepatocellular carcinoma.